Skip to main content
NIVF
NASDAQ Industrial Applications And Services

NewGen's K25.ai Stake Valued at $26M After Series A, Unrealized Gain of $8.5M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.86
Mkt Cap
$2.92M
52W Low
$0.819
52W High
$568.53
52W Position info
5.0% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

NIVF is trading near its 52-week low of $0.819 (5.0% above the low).

Summary

NewGen's 13% stake in K25.ai is now valued at ~US$26 million following K25.ai's Series A round, representing an ~US$8.5 million unrealized gain. The company also updated its expected share count to 5.9 million after a recent issuance.


Key Events · M&A and Partnerships · NIVF

  • K25.ai Stake Valued at $26M

    Based on K25.ai's Series A implied valuation of US$200 million, NewGen's agreed 13% stake is now worth approximately US$26 million, up from the original US$10 million investment.

  • Unrealized Gain of $8.5M

    The valuation step-up generates an expected unrealized gain of approximately US$8.5 million, significantly enhancing NewGen's balance sheet relative to its US$25.98 million in net assets at year-end 2025.

  • Post-Issuance Share Count Clarified

    Upon completion of the 2.5 million share issuance announced July 27, 2026, total outstanding Class A ordinary shares are expected to reach approximately 5.9 million.

  • 2025 Financials Disclosed

    NewGen reported net profit of US$9.9 million and net assets of US$25.98 million for fiscal year 2025, providing a baseline for the K25.ai investment's impact.


Analysis · NIVF · Industrial Applications And Services

NewGen disclosed that its agreed 13% stake in K25.ai is now worth approximately US$26 million based on a US$200 million implied valuation from K25.ai's recently closed Series A round, generating an expected unrealized gain of about US$8.5 million. This marks a significant step-up from the original US$10 million investment and materially strengthens NewGen's balance sheet, which reported net assets of US$25.98 million at year-end 2025. The company also expects total outstanding shares to reach 5.9 million after a previously announced 2.5 million share issuance, providing clarity on the post-dilution share count. For a micro-cap company with a going-concern history, this valuation uplift and the associated balance sheet improvement are critical positive developments.

At the time of this filing, NIVF was trading at $0.86 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $0.82 to $568.53. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NIVF - Latest Insights

NIVF
Jul 30, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.8584
Real-time Price: $0.8756 info
Change: +$0.0172 (+2%) info
Market Cap: $2.92M info
NIVF
Jul 27, 2026, 8:30 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.10
Real-time Price: $0.8756 info
Change: -$0.2244 (-20%) info
Market Cap: $2.92M info
NIVF
Jul 27, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.12
Real-time Price: $0.8756 info
Change: -$0.2444 (-22%) info
Market Cap: $2.92M info
NIVF
Jul 23, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.24
Real-time Price: $0.8756 info
Change: -$0.3682 (-30%) info
Market Cap: $2.92M info
NIVF
Jul 06, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
10
Price at Filing: $0.444
Real-time Price: $0.8756 info
Change: Reverse Stock Split info
Market Cap: $2.92M info